Healthcare Contracts Are Being Rewritten for AI, Privacy, and IP Risk
Nixon Peabody says healthcare technology contracts are moving beyond boilerplate as AI introduces new questions about privacy, intellectual property, and liability. The legal work now determines whether AI deployments can scale responsibly or get stuck in endless negotiation.
In healthcare AI, legal language is becoming operational infrastructure. The contract is no longer just a formal wrapper around a product purchase; it is where data rights, model ownership, output usage, confidentiality, and post-deployment accountability are defined.
That shift matters because AI systems do not behave like traditional software. They are trained, updated, integrated, and often dependent on sensitive data flows that raise distinct questions about HIPAA, patient consent, secondary data use, and who bears responsibility when a model’s output contributes to harm.
The most important point is that privacy and IP are now business issues, not just legal ones. Vendors want access to data to improve models; customers want assurances that their data will not be repurposed in ways that compromise competitiveness or compliance. The more useful the AI system, the more complex the contractual tradeoffs become.
This is why healthcare procurement is getting harder, not easier, in the AI era. The winners will likely be companies that can negotiate clear data boundaries and explain their governance model in plain language, because trust is increasingly encoded in the contract before it ever reaches the clinic.